Literature DB >> 23069210

The novel interaction between microspherule protein Msp58 and ubiquitin E3 ligase EDD regulates cell cycle progression.

Mario Benavides1, Lai-Fong Chow-Tsang, Jinsong Zhang, Hualin Zhong.   

Abstract

Microspherule protein Msp58 (or MCRS1) plays a role in numerous cellular processes including transcriptional regulation and cell proliferation. It is not well understood either how Msp58 mediates its myriad functions or how it is itself regulated. Here, by immunoprecipitation, we identify EDD (E3 identified by differential display) as a novel Msp58-interacting protein. EDD, also called UBR5, is a HECT-domain (homologous to E6-AP carboxy-terminus) containing ubiquitin ligase that plays a role in cell proliferation, differentiation and DNA damage response. Both in vitro and in vivo binding assays show that Msp58 directly interacts with EDD. Microscopy studies reveal that these two proteins co-localize in the nucleus. We have also found that depletion of EDD leads to an increase of Msp58 protein level and extends the half-life of Msp58, demonstrating that EDD negatively regulates Msp58's protein stability. Furthermore, we show that Msp58 is upregulated in multiple different cell lines upon the treatment with proteasome inhibitor MG132 and exogenously expressed Msp58 is ubiquitinated, suggesting that Msp58 is degraded by the ubiquitin-proteasome pathway. Finally, knockdown of either Msp58 or EDD in human lung fibroblast WI-38 cells affects the levels of cyclins B, D and E, as well as cell cycle progression. Together, these results suggest a role for the Msp58/EDD interaction in controlling cell cycle progression. Given that both Msp58 and EDD are often aberrantly expressed in various human cancers, our findings open a new direction to elucidate Msp58 and EDD's roles in cell proliferation and tumorigenesis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23069210      PMCID: PMC3518595          DOI: 10.1016/j.bbamcr.2012.10.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2.

Authors:  Jinsong Zhang; Markus Kalkum; Brian T Chait; Robert G Roeder
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

2.  The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints.

Authors:  Marcia A Munoz; Darren N Saunders; Michelle J Henderson; Jennifer L Clancy; Amanda J Russell; Gillian Lehrbach; Elizabeth A Musgrove; Colin K W Watts; Robert L Sutherland
Journal:  Cell Cycle       Date:  2007-09-07       Impact factor: 4.534

3.  Cooperation of HECT-domain ubiquitin ligase hHYD and DNA topoisomerase II-binding protein for DNA damage response.

Authors:  Yoshiomi Honda; Masahide Tojo; Kazuhito Matsuzaki; Tadashi Anan; Mitsuhiro Matsumoto; Masayuki Ando; Hideyuki Saya; Mitsuyoshi Nakao
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

4.  EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response.

Authors:  Michelle J Henderson; Amanda J Russell; Samantha Hird; Marcia Muñoz; Jennifer L Clancy; Gillian M Lehrbach; Sophina T Calanni; David A Jans; Robert L Sutherland; Colin K W Watts
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

5.  UV-damaged DNA-binding proteins are targets of CUL-4A-mediated ubiquitination and degradation.

Authors:  X Chen; Y Zhang; L Douglas; P Zhou
Journal:  J Biol Chem       Date:  2001-10-22       Impact factor: 5.157

6.  Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration.

Authors:  Ding-Yen Lin; Hsiu-Ming Shih
Journal:  J Biol Chem       Date:  2002-04-10       Impact factor: 5.157

7.  TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).

Authors:  A G Bader; M L Schneider; K Bister; M Hartl
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

8.  Depletion of a single nucleoporin, Nup107, prevents the assembly of a subset of nucleoporins into the nuclear pore complex.

Authors:  Thomas Boehmer; Jost Enninga; Samuel Dales; Gunter Blobel; Hualin Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

9.  EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer.

Authors:  Jennifer L Clancy; Michelle J Henderson; Amanda J Russell; David W Anderson; Ronaldo J Bova; Ian G Campbell; David Y H Choong; Graeme A Macdonald; Graham J Mann; Tania Nolan; Ged Brady; Olufunmilayo I Olopade; Erica Woollatt; Michael J Davies; Davendra Segara; Neville F Hacker; Susan M Henshall; Robert L Sutherland; Colin K W Watts
Journal:  Oncogene       Date:  2003-08-07       Impact factor: 9.867

10.  Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.

Authors:  Subbareddy Maddika; Junjie Chen
Journal:  Nat Cell Biol       Date:  2009-03-15       Impact factor: 28.824

View more
  10 in total

1.  The p90 ribosomal S6 kinase-UBR5 pathway controls Toll-like receptor signaling via miRNA-induced translational inhibition of tumor necrosis factor receptor-associated factor 3.

Authors:  Jin Hwa Cho; Sung Ah Kim; Yeon-Soo Seo; Sung Goo Park; Byoung Chul Park; Jeong-Hoon Kim; Sunhong Kim
Journal:  J Biol Chem       Date:  2017-05-30       Impact factor: 5.157

2.  MCRS1 Expression Regulates Tumor Activity and Affects Survival Probability of Patients with Gastric Cancer.

Authors:  Liang-Han Wang; Chih-Chun Chang; Chiao-Yin Cheng; Yao-Jen Liang; Dee Pei; Jen-Tang Sun; Yen-Lin Chen
Journal:  Diagnostics (Basel)       Date:  2022-06-20

3.  MCRS1 is essential for epiblast development during early mouse embryogenesis.

Authors:  Wei Cui; Agnes Cheong; Yongsheng Wang; Yuran Tsuchida; Yong Liu; Kimberly D Tremblay; Jesse Mager
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

4.  Glycogen synthase kinase (GSK) 3β phosphorylates and protects nuclear myosin 1c from proteasome-mediated degradation to activate rDNA transcription in early G1 cells.

Authors:  Aishe A Sarshad; Martin Corcoran; Bader Al-Muzzaini; Laura Borgonovo-Brandter; Anne Von Euler; Douglas Lamont; Neus Visa; Piergiorgio Percipalle
Journal:  PLoS Genet       Date:  2014-06-05       Impact factor: 5.917

5.  RanGTP aids anaphase entry through Ubr5-mediated protein turnover.

Authors:  Hao Jiang; Xiaonan He; Di Feng; Xueliang Zhu; Yixian Zheng
Journal:  J Cell Biol       Date:  2015-10-05       Impact factor: 10.539

6.  The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.

Authors:  Minxia Liu; Kecheng Zhou; Yunchao Huang; Yi Cao
Journal:  J Exp Clin Cancer Res       Date:  2015-10-14

7.  Use of a Conditional Ubr5 Mutant Allele to Investigate the Role of an N-End Rule Ubiquitin-Protein Ligase in Hedgehog Signalling and Embryonic Limb Development.

Authors:  Elaine Kinsella; Natalie Dora; David Mellis; Laura Lettice; Paul Deveney; Robert Hill; Mark Ditzel
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

8.  E3 ubiquitin ligase isolated by differential display regulates cervical cancer growth in vitro and in vivo via microRNA-143.

Authors:  Jibin Li; Xinling Wang; Yanshang Zhang; Yan Zhang
Journal:  Exp Ther Med       Date:  2016-06-06       Impact factor: 2.447

Review 9.  Gene mutations and actionable genetic lesions in mantle cell lymphoma.

Authors:  Makhdum Ahmed; Leo Zhang; Krystle Nomie; Laura Lam; Michael Wang
Journal:  Oncotarget       Date:  2016-09-06

10.  Regulation of hedgehog Ligand Expression by the N-End Rule Ubiquitin-Protein Ligase Hyperplastic Discs and the Drosophila GSK3β Homologue, Shaggy.

Authors:  Sophie Moncrieff; Matthieu Moncan; Flavia Scialpi; Mark Ditzel
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.